Enrofloxacin Production Cost Reports

The report provides a detailed analysis essential for establishing an Enrofloxacin production plant. It encompasses all critical aspects necessary for Enrofloxacin production, including the cost of Enrofloxacin production, Enrofloxacin plant cost, Enrofloxacin production costs, and the overall Enrofloxacin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Enrofloxacin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Enrofloxacin is predominantly used in veterinary medicine as a broad-spectrum fluoroquinolone antibiotic. It treats and prevents a wide range of bacterial infections in various animals, including pets like dogs and cats, as well as livestock such as cattle, pigs, sheep, goats, horses, and poultry. Common indications include skin and ear infections, urinary tract infections, respiratory infections (including enzootic pneumonia), gastrointestinal infections, mastitis, salmonellosis, and secondary infections during viral diseases.

It works by inhibiting bacterial DNA and RNA synthesis, leading to bactericidal effects against both gram-negative and gram-positive bacteria. Enrofloxacin is administered mostly via injections (intramuscular, subcutaneous, or intravenous) or orally, depending on the formulation and target species.

The market drivers for Enrofloxacin primarily include the increasing prevalence of bacterial infections in livestock and companion animals, which drives demand for effective antibiotics like Enrofloxacin. The global rise in pet ownership and enhanced veterinary care also significantly contributes to market growth. Additionally, expanding livestock populations, especially in Asia-Pacific and Latin America, coupled with rising meat consumption, fuel the demand for Enrofloxacin. Increasing awareness about animal health and welfare, growing veterinary healthcare infrastructure, and supportive government initiatives in emerging economies also contribute to the demand.

Technological advancements in drug formulation and delivery, such as long-acting injectables and targeted delivery systems, improve efficacy and reduce resistance risks, further propelling market growth. Moreover, procurement considerations vary based on the intended use in different animals (livestock, poultry, companion animals) and the dosage form needed (oral solution, injectable). Furthermore, bioavailability differences in species and administration methods influence formulation requirements, which in turn impact industrial enrofloxacin procurement.

Raw Material for Enrofloxacin Production

According to the Enrofloxacin production plant project report, the various raw materials for Enrofloxacin production include fluoroquinolonic acid and N-ethylpiperazine.

Manufacturing Process of Enrofloxacin

The extensive Enrofloxacin production cost report consists of the following major industrial production process:

1. Production via chemical synthesis: The production process of Enrofloxacin involves the reaction of 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (fluoroquinolonic acid) with N-ethylpiperazine in the presence of a catalyst called n-FZSA (nano iron oxide on ZrO2 coated sulfonic acid). The catalyst is magnetically removed post-reaction, and the product is isolated by filtration and recrystallisation with methanol.

Properties of Enrofloxacin

Enrofloxacin is a fluoroquinolone antibiotic characterised by a molecular formula of C19H22FN3O3 and a molecular weight of 359.39 g/mol. It appears as a pale yellow to light beige crystalline powder with a melting point around 225 degree Celsius. It is slightly soluble in water and more soluble in chloroform and dilute potassium hydroxide. It is stable under standard storage conditions. It is a zwitterionic molecule with pKa values near physiological pH, influencing its bioavailability and interaction with bacterial DNA gyrase, the target enzyme it inhibits.